Patients who experienced MACEs had a greater prevalence of CHD family history and significantly higher levels of apoB, TC, sdLDL-C, and Lp(a) [46.11 (41.18) nmol/L vs. 39.43 (39.87) nmol/L, p = 0.001] compared to patients who did not experience MACEs (Table 3). This evidence concerns the gene LPA and coronary artery disorder.